New patent for Abbvie Inc drug RINVOQ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for RINVOQ
Annual Drug Patent Expirations for RINVOQ

Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.

This drug has one hundred and forty-eight patent family members in forty-one countries.

The generic ingredient in RINVOQ is upadacitinib. One supplier is listed for this compound. Additional details are available on the upadacitinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top